ARHGEF12 and cancer: Lack of L-arg during cancer development has been linked to dysfunctional immune responses with inhibition of a favourable T-cell response and accumulation of myeloid-derived suppressor cells (MDSCs) and thereby functional impairment of T cells and poor prognosis (51, 52).